# The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients

> **NCT02599012** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Cancer
- Anemia

## Interventions

- **DRUG:** Ferinject®

## Key facts

- **NCT ID:** NCT02599012
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-12
- **Primary completion:** 2017-10
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02599012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02599012, "The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02599012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*